窪田製薬ホールディングス(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証GRT | 医薬品 | 4596/ - | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2017/05/12 | 日証協 | 296,900株 | -3.57% | 118,800株 | +2662.79% | 307,557株 | -0.49% | 28,500株 | +547.73% |
2017/05/02 | 日証協 | 307,900株 | -0.1% | 4,300株 | -95.31% | 309,057株 | -0.58% | 4,400株 | -85.58% |
2017/04/28 | 日証協 | 308,200株 | +2.39% | 91,600株 | -26.84% | 310,857株 | +1.01% | 30,510株 | +224.44% |
2017/04/21 | 日証協 | 301,000株 | +1.18% | 125,200株 | +100.64% | 307,747株 | +0.43% | 9,404株 | +67.6% |
2017/04/14 | 日証協 | 297,500株 | +4.61% | 62,400株 | -51.06% | 306,443株 | +2.96% | 5,611株 | -59.96% |
2017/04/07 | 日証協 | 284,400株 | +14.26% | 127,500株 | +44.89% | 297,632株 | +12.11% | 14,013株 | -77.29% |
2017/03/31 | 日証協 | 248,900株 | +10.81% | 88,000株 | +26.26% | 265,479株 | -3.91% | 61,700株 | +123.64% |
2017/03/24 | 日証協 | 224,621株 | +9.46% | 69,700株 | -32.98% | 276,290株 | +3.76% | 27,589株 | -24.07% |
2017/03/17 | 日証協 | 205,200株 | +8.8% | 104,000株 | +29.51% | 266,280株 | +13% | 36,334株 | +163.29% |
2017/03/10 | 日証協 | 188,600株 | +0.16% | 80,300株 | +12.46% | 235,656株 | +2.84% | 13,800株 | +141.98% |
2017/03/03 | 日証協 | 188,300株 | -2.28% | 71,400株 | +100.56% | 229,156株 | +39.51% | 5,703株 | +72.82% |
2017/02/24 | 日証協 | 192,700株 | -3.94% | 35,600株 | -51.37% | 164,254株 | -29.31% | 3,300株 | -41.09% |
2017/02/17 | 日証協 | 200,600株 | -8.15% | 73,200株 | -38.23% | 232,354株 | -9.92% | 5,602株 | -73.58% |
2017/02/10 | 日証協 | 218,400株 | +16.79% | 118,500株 | +764.96% | 257,952株 | +8.68% | 21,200株 | +51.42% |
2017/02/03 | 日証協 | 187,000株 | +5.23% | 13,700株 | +19.13% | 237,352株 | +0.98% | 14,001株 | +2.2% |
2017/01/27 | 日証協 | 177,700株 | +0.79% | 11,500株 | +125.49% | 235,051株 | +3.07% | 13,700株 | +77.92% |
2017/01/20 | 日証協 | 176,300株 | -0.96% | 5,100株 | -75.12% | 228,051株 | +2.43% | 7,700株 | -68.05% |
2017/01/13 | 日証協 | 178,000株 | -22.91% | 20,500株 | -49.63% | 222,651株 | -7.56% | 24,100株 | +125.23% |
2017/01/06 | 日証協 | 230,900株 | -0.39% | 40,700株 | -71.05% | 240,851株 | +1.04% | 10,700株 | -93.58% |
※株式分割は考慮していませんのでご注意ください。
Page Top